MetLife, Inc. $MET Shares Sold by Savant Capital LLC

Savant Capital LLC decreased its position in MetLife, Inc. (NYSE:MET) by 20.9% during the 2nd quarter, Holdings Channel reports. The fund owned 24,803 shares of the financial services provider’s stock after selling 6,547 shares during the quarter. Savant Capital LLC’s holdings in MetLife were worth $1,995,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Csenge Advisory Group raised its holdings in shares of MetLife by 1.0% in the 1st quarter. Csenge Advisory Group now owns 13,647 shares of the financial services provider’s stock valued at $1,096,000 after purchasing an additional 131 shares in the last quarter. Delta Investment Management LLC increased its holdings in MetLife by 0.9% in the first quarter. Delta Investment Management LLC now owns 14,265 shares of the financial services provider’s stock valued at $1,145,000 after buying an additional 133 shares during the last quarter. Ignite Planners LLC raised its stake in MetLife by 2.2% in the second quarter. Ignite Planners LLC now owns 6,366 shares of the financial services provider’s stock valued at $491,000 after buying an additional 136 shares in the last quarter. Glenview Trust co lifted its holdings in MetLife by 0.4% during the 1st quarter. Glenview Trust co now owns 38,333 shares of the financial services provider’s stock worth $3,078,000 after buying an additional 141 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. boosted its position in shares of MetLife by 1.0% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 14,902 shares of the financial services provider’s stock worth $1,198,000 after acquiring an additional 148 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Stock Performance

Shares of MET opened at $77.74 on Wednesday. The company’s 50 day simple moving average is $79.90 and its 200-day simple moving average is $78.89. The firm has a market cap of $51.70 billion, a PE ratio of 13.18, a price-to-earnings-growth ratio of 0.70 and a beta of 0.87. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.57.

MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share for the quarter, topping analysts’ consensus estimates of $2.30 by $0.07. The firm had revenue of $12.46 billion during the quarter, compared to analysts’ expectations of $18.64 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. MetLife’s quarterly revenue was down 5.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.95 EPS. As a group, equities analysts predict that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be given a $0.5675 dividend. This represents a $2.27 annualized dividend and a yield of 2.9%. The ex-dividend date is Tuesday, November 4th. MetLife’s payout ratio is 42.75%.

Wall Street Analysts Forecast Growth

MET has been the topic of several research analyst reports. Wells Fargo & Company cut their target price on MetLife from $96.00 to $92.00 and set an “overweight” rating on the stock in a research report on Friday, November 7th. Cowen reissued a “buy” rating on shares of MetLife in a report on Friday, August 22nd. Keefe, Bruyette & Woods reduced their price objective on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a research report on Tuesday. Jefferies Financial Group increased their target price on shares of MetLife from $100.00 to $103.00 and gave the company a “buy” rating in a research report on Monday, August 11th. Finally, UBS Group cut their price target on shares of MetLife from $96.00 to $95.00 and set a “buy” rating on the stock in a research note on Thursday, November 6th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $95.00.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.